{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:58:20Z","timestamp":1794265100336,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T00:00:00Z","timestamp":1312329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fibrogenesis Tissue Repair"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1755-1536-4-19","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T18:15:06Z","timestamp":1312395306000},"source":"Crossref","is-referenced-by-count":31,"title":["Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis"],"prefix":"10.1186","volume":"4","author":[{"given":"Toni","family":"Segovia-Silvestre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedrana","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Fern\u00e1ndez-Varo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Vassiliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Barascuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morales-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,3]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gut.2010.214650","volume":"59","author":"L Castera","year":"2010","unstructured":"Castera L, Pinzani M: Biopsy and non-invasive methods fot the diagnosis of liver fibrosis: does it take two to tango?. Gut. 2010, 59: 861-866. 10.1136\/gut.2010.214650.","journal-title":"Gut"},{"key":"58_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(09)62195-4","volume":"375","author":"L Castera","year":"2010","unstructured":"Castera L, Pinzani M: Non invasive assessment of liver fibrosis: are we ready?. Lancet. 2010, 375: 1419-1420. 10.1016\/S0140-6736(09)62195-4.","journal-title":"Lancet"},{"key":"58_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroeneterology. 2008, 134: 1655-1669. 10.1053\/j.gastro.2008.03.003.","journal-title":"Gastroeneterology"},{"key":"58_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344: 495-500. 10.1056\/NEJM200102153440706.","journal-title":"N Engl J Med"},{"key":"58_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","volume":"99","author":"NH Afdhal","year":"2004","unstructured":"Afdhal NH, Nunes D: Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004, 99: 1160-1174. 10.1111\/j.1572-0241.2004.30110.x.","journal-title":"Am J Gastroenterol"},{"key":"58_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3748\/wjg.15.2433","volume":"15","author":"AM Gressner","year":"2009","unstructured":"Gressner AM, Gao CF, Gressner OA: Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. World J Gastroenterol. 2009, 15: 2433-2440. 10.3748\/wjg.15.2433.","journal-title":"World J Gastroenterol"},{"key":"58_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrgastro.2009.197","volume":"7","author":"JA Talwalkar","year":"2010","unstructured":"Talwalkar JA: Antifibrotic therapies--emerging biomarkers as treatment end points. Nat Rev Gastroenterol Hepatol. 2010, 7: 59-61. 10.1038\/nrgastro.2009.197.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"58_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.gastro.2009.09.047","volume":"138","author":"JA Carrion","year":"2010","unstructured":"Carrion JA, Fernandez-Varo G, Bruguera M, Garcia-Pagan JC, Garcia-Valdecasas JC, Perez-Del-Pulgar S, et al: Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation. Gastroenterology. 2010, 138: 147-158. 10.1053\/j.gastro.2009.09.047.","journal-title":"Gastroenterology"},{"key":"58_CR9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clinchem\/42.4.558","volume":"42","author":"J Guechot","year":"1996","unstructured":"Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J: Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem. 1996, 42: 558-563.","journal-title":"Clin Chem"},{"key":"58_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0168-8278(95)80255-X","volume":"22","author":"J Guechot","year":"1995","unstructured":"Guechot J, Loria A, Serfaty L, Giral P, Guiboudeau J, Poupon R: Serum Hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol. 1995, 22: 22-26. 10.1016\/0168-8278(95)80255-X.","journal-title":"J Hepatol"},{"key":"58_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1440-1746.2001.02402.x","volume":"16","author":"I Shimizu","year":"2001","unstructured":"Shimizu I, Omoya T, Takaoka T, Wada S, Wada H, Taoka M, et al: Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following alpha-interferon therapy. J Gastroenterol Hepatol. 2001, 16: 196-201. 10.1046\/j.1440-1746.2001.02402.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"58_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/2010\/548263","volume":"28","author":"SS Veidal","year":"2010","unstructured":"Veidal SS, Bay-Jensen AC, Tougas G, Karsdal MA, Vainer B: Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers. Dis Markers. 2010, 28: 15-28.","journal-title":"Dis Markers"},{"key":"58_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","volume":"43","author":"N Barascuk","year":"2010","unstructured":"Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, et al: A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010, 43: 899-904. 10.1016\/j.clinbiochem.2010.03.012.","journal-title":"Clin Biochem"},{"key":"58_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1478-3231.2010.02309.x","volume":"30","author":"SS Veidal","year":"2010","unstructured":"Veidal SS, Vassiliadis E, Barascuk N, Zhang C, Segovia-Silvestre T, Klickstein L, et al: Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int. 2010, 30: 1293-1304. 10.1111\/j.1478-3231.2010.02309.x.","journal-title":"Liver Int"},{"key":"58_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0009-8981(97)00182-4","volume":"269","author":"CH Jensen","year":"1998","unstructured":"Jensen CH, Hansen M, Brandt J, Rasmussen HB, Jensen PB, Teisner B: Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms. Clin Chim Acta. 1998, 269: 31-41. 10.1016\/S0009-8981(97)00182-4.","journal-title":"Clin Chim Acta"},{"key":"58_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1742-4658.2007.05669.x","volume":"274","author":"HF Bigg","year":"2007","unstructured":"Bigg HF, Rowan AD, Barker MD, Cawston TE: Activity of matrix metalloproteinase- against native collagen types I and III. FEBS J. 2007, 274: 1246-1255. 10.1111\/j.1742-4658.2007.05669.x.","journal-title":"FEBS J"},{"key":"58_CR17","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/art.23654","volume":"58","author":"EY Zhen","year":"2008","unstructured":"Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, et al: Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum. 2008, 58: 2420-2431. 10.1002\/art.23654.","journal-title":"Arthritis Rheum"},{"key":"58_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4137\/BMI.S6347","volume":"6","author":"E Vassiliadis","year":"2011","unstructured":"Vassiliadis E, Vang Larsen D, Elgaard Clausen R, Veidal SS, Barascuk N, Larsen L, et al: Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type III, in a rat model of reversible carbon-tetrachloride-induced fibrosis. Biomarkers Insight. 2011, 6: 49-58.","journal-title":"Biomarkers Insight"},{"key":"58_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.21090","volume":"43","author":"A Blasco","year":"2006","unstructured":"Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilabert R, Rimola A, et al: Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006, 43: 492-499. 10.1002\/hep.21090.","journal-title":"Hepatology"},{"key":"58_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/bjs.6560","volume":"96","author":"S Yachida","year":"2009","unstructured":"Yachida S, Wakabayashi H, Okano K, Suzuki Y: Prediction of posthepatectomy hepatic functional reserve by serum hyaluronate. Br J Surg. 2009, 96: 501-508. 10.1002\/bjs.6560.","journal-title":"Br J Surg"},{"key":"58_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.gastro.2008.09.013","volume":"136","author":"V Nobili","year":"2009","unstructured":"Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, et al: Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology. 2009, 136: 160-167. 10.1053\/j.gastro.2008.09.013.","journal-title":"Gastroenterology"},{"key":"58_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/hep.22099","volume":"47","author":"RJ Fontana","year":"2008","unstructured":"Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, et al: Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008, 47: 789-798. 10.1002\/hep.22099.","journal-title":"Hepatology"},{"key":"58_CR23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0016-5085(79)80170-5","volume":"76","author":"M Rojkind","year":"1979","unstructured":"Rojkind M, Giambrone MA, Biempica L: Collagen types in normal and cirrhotic liver. Gastroenterology. 1979, 76: 710-719.","journal-title":"Gastroenterology"},{"key":"58_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1172\/JCI114643","volume":"85","author":"H Nakatsukasa","year":"1990","unstructured":"Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 1990, 85: 1833-1843. 10.1172\/JCI114643.","journal-title":"J Clin Invest"},{"key":"58_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJM199104043241401","volume":"324","author":"A Castilla","year":"1991","unstructured":"Castilla A, Prieto J, Fausto N: Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med. 1991, 324: 933-940. 10.1056\/NEJM199104043241401.","journal-title":"N Engl J Med"},{"key":"58_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0168-8278(92)90168-O","volume":"14","author":"G Annoni","year":"1992","unstructured":"Annoni G, Weiner FR, Zern MA: Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol. 1992, 14: 259-264. 10.1016\/0168-8278(92)90168-O.","journal-title":"J Hepatol"},{"key":"58_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann S, Graf J, Roderfeld M, Roeb E: Expression of MMPs and TIMPs in liver fibrosis -- a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol. 2007, 46: 955-975. 10.1016\/j.jhep.2007.02.003.","journal-title":"J Hepatol"},{"key":"58_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/hep.1840210328","volume":"21","author":"T Takahara","year":"1995","unstructured":"Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, et al: Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology. 1995, 21: 787-795. 10.1002\/hep.1840210328.","journal-title":"Hepatology"},{"key":"58_CR29","first-page":"528","volume":"144","author":"S Milani","year":"1994","unstructured":"Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, et al: Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol. 1994, 144: 528-537.","journal-title":"Am J Pathol"},{"key":"58_CR30","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0002-9440(10)65703-3","volume":"153","author":"AE Kossakowska","year":"1998","unstructured":"Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, et al: Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol. 1998, 153: 1895-1902. 10.1016\/S0002-9440(10)65703-3.","journal-title":"Am J Pathol"},{"key":"58_CR31","first-page":"443","volume":"113","author":"T Knittel","year":"2000","unstructured":"Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G: Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem. Cell Biol. 2000, 113: 443-453.","journal-title":"Cell Biol"},{"key":"58_CR32","doi-asserted-by":"publisher","first-page":"G1324","DOI":"10.1152\/ajpgi.90564.2008","volume":"296","author":"RG Gieling","year":"2009","unstructured":"Gieling RG, Wallace K, Han YP: Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009, 296: G1324-1331. 10.1152\/ajpgi.90564.2008.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"58_CR33","doi-asserted-by":"publisher","first-page":"37585","DOI":"10.1074\/jbc.M611500200","volume":"282","author":"P Vempati","year":"2007","unstructured":"Vempati P, Karagiannis ED, Popel AS: A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem. 2007, 282: 37585-37596. 10.1074\/jbc.M611500200.","journal-title":"J Biol Chem"},{"key":"58_CR34","first-page":"379","volume-title":"The Liver and the Kidney","author":"J Cl\u00e0ria","year":"1999","unstructured":"Cl\u00e0ria J, Jim\u00e9nez W: Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats. The Liver and the Kidney. Edited by: Arroyo V, Schrier RW, Rod\u00e9s J, Gin\u00e8s P. Boston: Blackwell Science. 1999, 379-396."},{"key":"58_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1124\/jpet.107.131896","volume":"324","author":"J Mu\u00f1oz-Luque","year":"2008","unstructured":"Mu\u00f1oz-Luque J, Ros J, Fern\u00e1ndez-Varo G, Tugues S, Morales-Ruiz M, Alvarez CE, et al: Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther. 2008, 324: 475-483.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Fibrogenesis & Tissue Repair"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-1536-4-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1755-1536-4-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-1536-4-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:10:03Z","timestamp":1592784603000},"score":1,"resource":{"primary":{"URL":"https:\/\/fibrogenesis.biomedcentral.com\/articles\/10.1186\/1755-1536-4-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1186\/1755-1536-4-19","relation":{},"ISSN":["1755-1536"],"issn-type":[{"value":"1755-1536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,3]]},"article-number":"19"}}